Vertex Pharmaceuticals (VRTX) Amortizatization of Intangibles (2010 - 2011)
Vertex Pharmaceuticals (VRTX) posted Amortizatization of Intangibles of $6.6 million for Q4 2011, up 145.52% on a QoQ basis from $2.7 million in Q3 2011, and up 83.66% year-over-year from $3.6 million in Q4 2010.
Powered by 
Analysis
Vertex Pharmaceuticals (VRTX) Amortizatization of Intangibles (2010 - 2011) Analysis & Trends
Vertex Pharmaceuticals has reported Amortizatization of Intangibles for 2 years, with the latest figure at $6.6 million in Q4 2011.
- On a quarterly basis, Amortizatization of Intangibles rose 83.66% year-over-year to $6.6 million in Q4 2011; TTM through Dec 2011 was $19.4 million, a 42.73% increase from a year earlier, with the FY2011 full-year figure at $18.4 million, up 35.47% from the prior year.
- Amortizatization of Intangibles was $6.6 million for Q4 2011 at Vertex Pharmaceuticals, up from $2.7 million in the prior quarter.
- The five-year high for Amortizatization of Intangibles was $6.6 million in Q1 2011, with the low at $2.7 million in Q3 2011.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 208.48 Bn | 194.49 Bn | 7.24 Bn | - |
| 2 | Gilead Sciences | 186.29 Bn | 183.02 Bn | 6.22 Bn | 600.00 Mn |
| 3 | Vertex Pharmaceuticals | 128.79 Bn | 120.93 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 80.66 Bn | 72.67 Bn | 3.93 Bn | - |
| 5 | Moderna | 61.46 Bn | 56.32 Bn | 52.00 Mn | - |
| 6 | Argenx Se | 61.28 Bn | 56.10 Bn | 1.37 Bn | - |
| 7 | Alnylam Pharmaceuticals | 32.04 Bn | 28.73 Bn | 992.69 Mn | - |
| 8 | Biogen | 31.84 Bn | 30.56 Bn | 1.96 Bn | - |
| 9 | Roivant Sciences | 28.74 Bn | 29.43 Bn | 1.16 Mn | 1.39 Mn |
| 10 | Insmed | 26.19 Bn | 25.03 Bn | 358.27 Mn | 678,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2011 | 6.55 Mn |
| Sep 30, 2011 | 2.67 Mn |
| Mar 31, 2011 | 6.61 Mn |
| Dec 31, 2010 | 3.57 Mn |
| Sep 30, 2010 | 3.45 Mn |
| Jun 30, 2010 | 3.34 Mn |
| Mar 31, 2010 | 3.23 Mn |